Candido, Riccardo
Di Loreto, Chiara
Desenzani, Paolo
Pantanetti, Paola
Romano, Cristina
Settembrini, Silvio
Solerte, Sebastiano Bruno
Fadini, Gian Paolo http://orcid.org/0000-0002-6510-2097
Article History
Received: 23 May 2024
Accepted: 9 July 2024
First Online: 22 July 2024
Declarations
:
: Riccardo Candido declared to receive: an honoraria for advisory board membership from Novo Nordisk; consulting fees from Abbott, Novo Nordisk, Sanofi, Aventis, MSD Italia, Eli Lilly, Menarini Diagnostics, Bayer; honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events from Boehringer Ingelheim, Novo Nordisk, Eli Lilly, Roche Diabetes Care, Sanofi-Aventis. Chiara Di Loreto declared to receive: an honoraria for advisory board membership from Novo Nordisk and Lilly, consulting fees from Novo Nordisk; honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events from Abbott, Novo Nordisk, Roche Diabetes Care. Gian Paolo Fadini is an Editorial Board member of<i> Diabetes Therapy</i>. Gian Paolo Fadini was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Gian Paolo Fadini declared to receive: an honoraria for advisory board membership from Novo Nordisk; consulting fees from AstraZeneca and Lilly; honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events from Abbott, Novo Nordisk, AstraZeneca, Servier, Boehringer, Lilly; support for attending meetings and/or travel from Novo Nordisk. Cristina Romano, Paolo Desenzani, Paola Pantanetti, Silvio Settembrini, Sebastiano Bruno Solerte declare no competing interests.
: Ethical review by an ethics committee was not applicable as this article is based on previously conducted studies and direct observations from real-world clinical practice. Case reports derive from authors’ daily practice on clinical use of oral semaglutide. Written informed consent was obtained from each patient for the publication of the data reported in the case reports.